What are the clinical presentation, imaging findings, and management recommendations for subdural hematoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Subdural Hematoma: Clinical Presentation, Imaging, and Management

Clinical Presentation

Subdural hematoma presents with a spectrum of symptoms ranging from headache and altered consciousness to focal neurological deficits and coma, with the severity depending on hematoma size, acuity, and patient age. 1

Key Clinical Features to Assess:

  • Glasgow Coma Scale (GCS) score, particularly motor response, as this determines surgical urgency and predicts outcomes 2
  • Pupillary examination for anisocoria or bilateral mydriasis, which indicates herniation risk and constitutes an absolute indication for immediate surgery 2
  • Focal neurological deficits including motor weakness, sensory changes, or speech disturbances 1
  • Symptoms of increased intracranial pressure: severe headache, vomiting, progressive deterioration over minutes to hours 1
  • Level of consciousness changes, including disorientation and confusion 3

High-Risk Populations:

  • Elderly patients (≥65 years) are at significantly higher risk, with ground-level falls accounting for 34.6% of deaths in this age group 4
  • Anticoagulated patients have dramatically increased risk, with 30% of fatal cases involving aspirin, warfarin, clopidogrel, or heparin use 4
  • Patients on clopidogrel have particularly high mortality (OR = 14.7) after traumatic intracranial hemorrhage 4

Imaging Findings

Non-contrast CT is the mandatory gold-standard for detecting acute subdural hematoma and must be obtained emergently. 1, 2

CT Imaging Protocol:

  • Obtain initial CT within 3 hours of symptom onset, as 28-38% of patients demonstrate hematoma expansion on subsequent imaging 1, 2
  • Measure maximal hematoma thickness and degree of midline shift, as these determine surgical urgency 2
  • Assess for mass effect indicators: compressed basal cisterns, midline shift >5mm, ventricular collapse 2

Acute Subdural Hematoma Appearance:

  • Homogenous, crescent-shaped hyperdense extra-axial collection 5
  • Located between dura mater and arachnoid membrane 6

Advanced Imaging Indications:

  • CT angiography can identify patients at high risk for hematoma expansion by revealing contrast extravasation within the hematoma 1, 2
  • MRI of brain with contrast and whole spine should be performed when subdural hematoma occurs without clear trauma history to investigate for spontaneous intracranial hypotension and CSF leak 2, 7
  • MRI provides better characterization of subacute and chronic subdural collections and can detect smaller hematomas missed on CT 4

Management Recommendations

Immediate Surgical Indications

Perform immediate surgical evacuation when subdural hematoma thickness exceeds 5mm AND midline shift exceeds 5mm, or when the patient shows neurological deterioration or decreased consciousness. 2

The appearance of anisocoria, bilateral mydriasis, or other signs of brain herniation constitutes an absolute indication for immediate surgical evacuation. 2

Additional surgical triggers include:

  • GCS decline of 2 points or more 2
  • Symptomatic hematoma with significant mass effect 2
  • Progressive neurological deterioration 2

Surgical Approach

Burr hole drainage is the preferred first-line surgical approach for chronic subdural hematomas, with subdural drain placement to reduce recurrence rates. 2

  • Burr-hole drainage with irrigation and closed-system drainage is recommended as initial treatment, with reoperation rates of approximately 16% 8
  • Extended craniotomy with membranectomy is reserved for acute rebleeding with solid hematoma, as it offers no advantages regarding reoperation rates or outcomes 8
  • Decompressive craniectomy should be considered for patients with refractory intracranial hypertension after multidisciplinary discussion 2

Conservative Management

Conservative management with close monitoring is appropriate for stable patients without significant neurological deficits, particularly for small or asymptomatic hematomas. 2

Conservative management requires:

  • Regular neurological assessments 2
  • Maintaining euvolemia (avoiding hypervolemia, which does not improve outcomes) 2
  • Serial imaging to monitor for progression 2

Anticoagulation Management

Rapidly reverse anticoagulation using prothrombin complex concentrate plus vitamin K for patients on anticoagulation who develop subdural hematoma. 1, 2

Pre-Surgical Coagulation Targets:

  • Prothrombin time/aPTT should be <1.5 times normal control prior to any neurosurgical procedure 2
  • Platelet count >50,000/mm³ is the minimum required; higher thresholds are advisable for neurosurgical operations 2
  • Use point-of-care viscoelastic testing (TEG/ROTEM) when available to optimize coagulation status before intervention 2

Anticoagulation Resumption:

  • Restart anticoagulation approximately 4 weeks after surgical removal of traumatic subdural hematoma if no ongoing fall risk or alcohol abuse is present 2
  • The duration of anticoagulation interruption is typically 7-15 days, with low risk of ischemic events during this period 2

Hemodynamic and ICP Management

Blood Pressure Targets:

  • Maintain systolic blood pressure >100 mmHg OR mean arterial pressure >80 mmHg during emergency interventions 2
  • In adults without multimodal neuromonitoring, maintain cerebral perfusion pressure (CPP) between 60-70 mmHg 2
  • CPP >70 mmHg is not recommended as it increases respiratory distress syndrome risk five-fold without neurological benefit 2
  • CPP <60 mmHg is associated with poorer neurological outcomes 2
  • Reference MAP at the level of the external ear tragus for CPP calculation 2

Respiratory Targets:

  • Target PaO₂ between 60-100 mmHg throughout all interventions 2
  • Target PaCO₂ between 35-40 mmHg throughout all interventions 2
  • Continuously monitor end-tidal CO₂ in intubated patients 2

ICP Monitoring Indications:

ICP monitoring is not required when the initial non-contrast CT scan is normal and there are no clinical severity indicators. 2

ICP monitoring after subdural hematoma evacuation is indicated if any one of the following is present: 2

  • Pre-operative motor response on GCS ≤5
  • Pre-operative anisocoria or bilateral mydriasis
  • Pre-operative hemodynamic instability
  • Compressed basal cisterns, midline shift >5mm, or other intracranial lesions
  • Intra-operative cerebral edema
  • Post-operative emergence of new intracranial lesions

Intraparenchymal ICP probes are preferred over intraventricular drains because they have lower infection rates (≈2.5% vs 10%) and lower hemorrhage risk (0-1% vs 2-4%) 2

ICP Treatment:

  • For impending cerebral herniation, employ osmotherapy and/or temporary hypocapnia while awaiting emergency neurosurgery 2
  • Apply external ventricular drainage for persistent intracranial hypertension unresponsive to sedation 2

Transfusion Thresholds

  • Transfuse packed red blood cells when hemoglobin falls below 7 g/dL during emergency care 2
  • Consider higher hemoglobin threshold for transfusion in elderly patients or those with cardiovascular disease 2

Special Considerations

Spontaneous Intracranial Hypotension:

When subdural hematoma occurs without clear trauma history, perform MRI of brain with contrast and whole spine to investigate for spinal CSF leak. 2, 7

  • Treat the underlying CSF leak as the primary management strategy 7
  • Epidural blood patch should be prioritized as initial treatment 7
  • Small or asymptomatic hematomas should be managed conservatively while treating the CSF leak 7
  • Symptomatic hematomas with significant mass effect may need burr hole drainage in conjunction with treating the leak 7

Elderly Patients:

  • Triage set points should be lower, with systolic blood pressure <110 mmHg considered significant 4
  • Brain atrophy creates more space for brain movement during impact, increasing strain on bridging veins 4
  • Mortality risk increases further after age 74 (1.67 higher odds of death) 4

Recurrence Risk:

  • Recurrence remains the principal complication (9-33%), occurring more commonly with older age, bilateral subdural hematomas, and coagulopathy 3
  • In patients with coagulopathy, the reoperation rate is 41%, significantly higher than 12% in non-coagulopathic patients 8

Critical Pitfalls to Avoid

  • Do not delay surgical intervention when neurological deterioration occurs, as this leads to poorer outcomes 2
  • Avoid hypervolemia, as it does not improve outcomes and may cause complications 2
  • Do not routinely use antiepileptic drugs for primary prevention of post-traumatic seizures, as they show no benefit and may worsen neurological outcomes 2
  • Do not attempt to determine the age of subdural hematomas by imaging alone, as care should be taken with this assessment 4
  • Do not discharge anticoagulated patients with head trauma without appropriate imaging and observation, as delayed hemorrhage can occur 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Subdural Hematoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Fatal Acute Subdural Hemorrhage from Low-Energy Falls

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Chronic subdural hematoma: What precisely are we treating?

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences, 2024

Research

Nontraumatic bilateral subdural hematoma: Case report.

Annals of medicine and surgery (2012), 2021

Guideline

Treatment of Subdural Hygroma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.